当前位置: 首页 > 详情页

Effects of different surgical modalities on the clinical outcome of patients with moyamoya disease: a prospective cohort study

文献详情

资源类型:

收录情况: ◇ SCIE

机构: [1]Departments of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University [2]China National Clinical Research Center for Neurological Diseases [3]Center of Stroke, Beijing Institute for Brain Disorders [4]Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China [5]Departments of Neurology, Beijing Tiantan Hospital, Capital Medical University
出处:
ISSN:

关键词: moyamoya disease bypass surgery revascularization stroke intracranial hemorrhage vascular disorders

摘要:
OBJECTIVE Bypass surgery is the most common treatment for moyamoya disease (MMD), but there is controversy over which surgical modality is best. The objective of this study was to evaluate the clinical outcome of patients with MMD after undergoing different surgical modalities. METHODS A series of 696 consecutive MMD patients treated between June 2009 and May 2015 were screened in this prospective cohort study. Patients who did not undergo revascularization surgeries and those who underwent different surgical modalities in bilateral hemispheres were excluded. Finally, 529 patients who were observed for at least 12 months were included: 438 patients underwent unilateral surgery, and 91 patients underwent bilateral surgery. Of these, 241 patients underwent direct bypass (DB); 81, a combined bypass (CB); and 207, an indirect bypass (IB). Three clinical outcomes were evaluated and compared between surgical groups: recurrent stroke events, modified Rankin Scale (mRS) scores, and change in the main symptoms. RESULTS The mean follow-up period was 40 months. During the follow-up period, recurrent stroke was observed in 43 patients, including 15 patients with hemorrhage, 26 patients with ischemia (transient ischemic attack in 19 patients and infarction in 7 patients), and 2 patients with both hemorrhage and cerebral infarction. Kaplan-Meier analysis showed that patients who underwent a CB or DB had a longer ischemia-free time than those who underwent IB (p = 0.013); however, there was no significant difference in the hemorrhage-free time between the different surgical modalities (p = 0.534). A good neurological status (mRS score = 2) was achieved in 495 patients (93.6%) and was significantly achieved by more children (98.2%) than adults (92.3%; p = 0.022). Surgical modalities were not significantly associated with outcome neurological status (p = 0.860). Moreover, improvement in symptoms was observed in 449 patients (84.9%) and was also significantly more common in children (93.0%) than in adults (82.7%; p = 0.006). No significant difference was observed between the different surgical modalities (p = 0.548). CONCLUSIONS CB and DB are more effective at preventing recurrent ischemic strokes than IB. However, there is no evidence that these 3 surgical modalities demonstrate significant differences in preventing recurrent hemorrhage.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2017]版:
大类 | 2 区 医学
小类 | 2 区 临床神经病学 2 区 外科
最新[2023]版:
大类 | 2 区 医学
小类 | 2 区 临床神经病学 2 区 外科
JCR分区:
出版当年[2016]版:
Q1 SURGERY Q1 CLINICAL NEUROLOGY
最新[2023]版:
Q1 CLINICAL NEUROLOGY Q1 SURGERY

影响因子: 最新[2023版] 最新五年平均 出版当年[2016版] 出版当年五年平均 出版前一年[2015版] 出版后一年[2017版]

第一作者:
第一作者机构: [1]Departments of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University [2]China National Clinical Research Center for Neurological Diseases [3]Center of Stroke, Beijing Institute for Brain Disorders [4]Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China
共同第一作者:
通讯作者:
通讯机构: [1]Departments of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University [2]China National Clinical Research Center for Neurological Diseases [3]Center of Stroke, Beijing Institute for Brain Disorders [4]Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China [*1]Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16409 今日访问量:0 总访问量:869 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院